Qian Cheng
- Oncology top 10%
- Cancer-related Molecular Pathways 11
- Cancer Research top 10%
-
- Ubiquitin and proteasome pathways 8
- Epigenetics and DNA Methylation 3
- DNA Repair Mechanisms 2
- Biotechnology top 10%
- Cancer Research and Treatments 4
-
- Hepatocellular Carcinoma Treatment and Prognosis 2
- Liver physiology and pathology 2
-
- Liver Disease Diagnosis and Treatment 2
- Co-authors
- Jiandong ChenLihong ChenZhenyu LiBaozong LiWilliam S. LaneGong YangXiaofei ZhangHuijing Yin
- Journals
- Journal of Biological Chemistry (1 paper)SHILAP Revista de lepidopterología (1 paper)The EMBO Journal (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Qian Cheng
25 papers receiving 870 citations
Peers
Comparison fields: 5 of 81
- Oncology 450
- Cancer Research 167
- Molecular Biology 607
- Biotechnology 75
- Developmental Neuroscience 26
Countries citing papers authored by Qian Cheng
This map shows the geographic impact of Qian Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qian Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qian Cheng more than expected).
Fields of papers citing papers by Qian Cheng
This network shows the impact of papers produced by Qian Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qian Cheng. The network helps show where Qian Cheng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Qian Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2021 | 48 | |
| 4 | 2020 | 20 | |
| 5 | 2020 | 14 | |
| 6 | ADAR1 may be involved in the proliferation of acute myeloid leukemia cells via regulation of the Wnt pathway | 2019 | 1 |
| 7 | 2019 | 4 | |
| 8 | 2019 | 27 | |
| 9 | 2018 | 18 | |
| 10 | 2017 | 45 | |
| 11 | 2016 | 35 | |
| 12 | 2015 | 55 | |
| 13 | 2014 | 20 | |
| 14 | 2013 | 24 | |
| 15 | 2011 | 55 | |
| 16 | 2011 | 26 | |
| 17 | 2011 | 18 | |
| 18 | 2010 | 169 | |
| 19 | 2010 | 55 | |
| 20 | 2009 | 126 |
About Qian Cheng
Qian Cheng is a scholar working on Oncology, Biotechnology and Hepatology, having authored 25 papers that have together received 883 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (11 papers), Ubiquitin and proteasome pathways (8 papers), Cancer Research and Treatments (4 papers), Epigenetics and DNA Methylation (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), DNA Repair Mechanisms (2 papers), Liver physiology and pathology (2 papers) and Liver Disease Diagnosis and Treatment (2 papers). The work is most often cited by research in Oncology (450 citations), Cancer Research (167 citations) and Molecular Biology (607 citations). Qian Cheng has collaborated with scholars based in China and United States. Frequent co-authors include Jiandong Chen, Lihong Chen, Zhenyu Li, Baozong Li, William S. Lane, Gong Yang, Xiaofei Zhang, Huijing Yin, Changhong Miao and Tanjing Song. Their work appears in journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.